Continuing its Japanese homage, Cherry Audio reignites three of Roland’s finest synths from the '70s, in a single soft-synth ...
Photonics is promising to handle extensive vector multiplications in AI applications. Scientists in China have promoted a programmable and reconfigurable photonic linear vector machine named SUANPAN, ...
As an innovative subtype of invasive brain-computer interfaces (BCIs), the Endovascular Brain-Computer Interface (EBCI) enables electrode delivery to target brain regions via endovascular intervention ...
Morning Overview on MSN
Scientists finally solve 30-year cancer riddle buried in rye pollen
A team of chemists led by Northwestern University has resolved a structural mystery that lingered for roughly three decades, ...
BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment ...
Karyopharm Therapeutics (NASDAQ:KPTI) executives highlighted upcoming late-stage clinical catalysts, continued revenue growth ...
Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia Rilzabrutinib is the first and only investigational BTKi ...
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing ...
February 11, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...
Send your raiders on Expeditions to prestige your account.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results